The involvement of the cerebellum in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 7-8, 2013, Pages 507-515

  Prell, Tino ^a   Grosskreutz, Julian ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Diffusion tensor imaging; Superoxide dismutase; TDP43; Ubiquitin; Voxel based morphometry

Indexed keywords

PROTEIN P62; TAR DNA BINDING PROTEIN; TAU PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; CEREBELLUM; DIFFUSION TENSOR IMAGING; IMMUNOHISTOCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CEREBELLUM; DNA DAMAGE; HUMANS; NEUROIMAGING;

EID: 84887490221     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.812661     Document Type: Review

References (63)

1. swijk M, DeJesus-Hernandez M, Rademakers R. How do C9orf72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other non-coding repeat expansion disorders Curr Opin Neurol. 2012; 25:689-700.
2. Renton A E, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9orf72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72:257-68.
3. Hibi M, Shimizu T. D evelopment of the cerebellum and cerebellar neural circuits. Dev Neurobiol. 2012; 72:282-301.
4. Ito M. C ontrol of mental activities by internal models in the cerebellum. Nat Rev Neurosci. 2008; 9:304-13.
5. Hashimoto M, Hibi M. D evelopment and evolution of cerebellar neural circuits. Dev Growth Differ. 2012; 54:373-89.
6. Takahashi H, Oyanagi K, Ikuta F, Tanaka M, Yuasa T, Miyatake T. Widespread multiple system degeneration in a patient with familial amyotrophic lateral sclerosis. J Neurol Sci. 1993; 120:15-21.
7. Hirano A, Kurland LT, Sayre GP. F amilial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol. 1967; 16:232-43.
8. Swash M, Scholtz CL, Vowles G, Ingram DA. S elective and asymmetric vulnerability of corticospinal and spinocerebellar tracts in motor neuron disease. J Neurol Neurosurg Psychiatry. 1988; 51:785-9.
9. Nakano T, Nakaso K, Nakashima K, Ohama E. E xpression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of fi ve autopsy cases with broad clinicopathological spectrum. Acta Neuropathol. 2004; 107:359-64.
10. Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM. Ubiquitin deposits in anterior horn cells in motor neuron disease. Neurosci Lett. 1988; 93:197-203.
11. Al Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, et al. p62-positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus defi ne the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011; 122:691-702.
12. Mackenzie I R, Rademakers R, Neumann M. T DP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010; 9:995-1007.
13. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive taunegative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006; 351:602-11.
14. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314:130-3.
15. F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol. 2009; 66:180-9.
16. Seibenhener M L, Babu J R, Geetha T, Wong H C, Krishna NR, Wooten MW. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol. 2004; 24:8055-68.
17. Moscat J, Diaz-Meco M T, Wooten M W. S ignal integration and diversifi cation through the p62 scaffold protein. Trends Biochem Sci. 2007; 32:95-100.
18. Kuusisto E, Salminen A, Alafuzoff I. U biquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport. 2001; 12:2085-90.
19. Seppanen A, Pikkarainen M, Hartikainen P, Hofmann S C, Majamaa K, Alafuzoff I. Expression of collagen XVII and ubiquitin-binding protein p62 in motor neuron disease. Brain Res. 2009; 1247:171-7.
20. King A, Maekawa S, Bodi I, Troakes C, Al Sarraj S. U biquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43. Neuropathology. 2011; 31:239-49.
21. Pikkarainen M, Hartikainen P, Alafuzoff I. N europathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J Neuropathol Exp Neurol. 2008; 67:280-98.
22. King A, Al Sarraj S, Shaw C. F rontotemporal lobar degeneration with ubiquitinated tau-negative inclusions and additional alpha-synuclein pathology but also unusual cerebellar ubiquitinated p62-positive, TDP-43-negative inclusions. Neuropathology. 2009; 29:466-71.
23. Troakes C, Maekawa S, Wijesekera L, Rogelj B, Siklos L, Bell C, et al. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology. 2012; 32:505-14.
24. Kuusisto E, Kauppinen T, Alafuzoff I. U se of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol Appl Neurobiol. 2008; 34:169-80.
25. Bigio E H, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, et al. Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9orf72: clinicopathologic correlation. Neuropathology. 2013; 33:122-33.
26. Mochizuki Y, Isozaki E, Takao M, Hashimoto T, Shibuya M, Arai M, et al. Familial ALS with FUS P525L mutation: two Japanese sisters with multiple systems involvement. J Neurol Sci. 2012; 323:85-92.
27. Lee J C, Joo K M, Choe S Y, Cha C I. R egion-specifi c changes in the immunoreactivity of TRPV4 expression in the central nervous system of SOD1-G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis. J Mol Histol. 2012; 43:625-31.
28. Chung Y H, Joo K M, Lim H C, Cho M H, Kim D, Lee W B, et al. Immunohistochemical study on the distribution of phosphorylated extracellular signal-regulated kinase (ERK) in the central nervous system of SOD1-G93A transgenic mice. Brain Res. 2005; 1050:203-9.
29. Cha CI, Chung YH, Shin CM, Shin DH, Kim YS, Gurney ME, et al. Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation. Brain Res. 2000; 853:156-61.
30. Baranczyk-Kuzma A, Usarek E, Kuzma-Kozakiewcz M, Kazmierczak B, Gajewska B, Schwalenstocker B, et al. Agerelated changes in tau expression in transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res. 2007; 32:415-21.
31. Kim SH, Engelhardt JI, Henkel JS, Siklos L, Soos J, Goodman C, et al. Widespread increased expression of the DNA repair enzyme PARP in brain in ALS. Neurology. 2004; 62:319-22.
32. Chung YH, Joo KM, Lee YJ, Shin DH, Cha CI. R eactive astrocytes express PARP in the central nervous system of SOD1-G93A transgenic mice. Brain Res. 2004; 1003:199-204.
33. Lule D, Ludolph AC, Kassubek J. M RI-based functional neuroimaging in ALS: an update. Amyotroph Lateral Scler. 2009; 10:258-68.
34. Konrad C, Henningsen H, Bremer J, Mock B, Deppe M, Buchinger C, et al. Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Exp Brain Res. 2002; 143:51-6.
35. Konrad C, Jansen A, Henningsen H, Sommer J, Turski PA, Brooks BR, et al. Subcortical reorganization in amyotrophic lateral sclerosis. Exp Brain Res. 2006; 172:361-9.
36. Schoenfeld MA, Tempelmann C, Gaul C, Kuhnel GR, Duzel E, Hopf JM, et al. Functional motor compensation in amyotrophic lateral sclerosis. J Neurol. 2005; 252:944-52.
37. Han J, Ma L. F unctional magnetic resonance imaging study of the brain in patients with amyotrophic lateral sclerosis. Chin Med Sci J. 2006; 21:228-33.
38. Agosta F, Valsasina P, Absinta M, Riva N, Sala S, Prelle A, et al. Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb Cortex. 2011; 21:2291-8.
39. Cistaro A, Valentini M C, Chio A, Nobili F, Calvo A, Moglia C, et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging. 2012; 39:251-9.
40. Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology. 2010; 75:1645-52.
41. Douaud G, Filippini N, Knight S, Talbot K, Turner MR. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain. 2011; 134:3470-9.
42. Maekawa S, Al Sarraj S, Kibble M, Landau S, Parnavelas J, Cotter D, et al. Cortical selective vulnerability in motor neuron disease: a morphometric study. Brain. 2004; 127:1237-51.
43. Kassubek J, Unrath A, Huppertz HJ, Lule D, Ethofer T, Sperfeld AD, et al. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel based morphometry of 3-D MRI. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6:213-20.
44. Thivard L, Pradat PF, Lehericy S, Lacomblez L, Dormont D, Chiras J, et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J Neurol Neurosurg Psychiatry. 2007; 78:889-92.
45. Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9orf72, tau, progranulin and sporadics. Brain. 2012; 135:794-806.
46. Grosskreutz J, Peschel T, Unrath A, Dengler R, Ludolph AC, Kassubek J. Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph Lateral Scler. 2008; 9:238-48.
47. Sach M, Winkler G, Glauche V, Liepert J, Heimbach B, Koch MA, et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain. 2004; 127:340-50.
48. Abe O, Yamada H, Masutani Y, Aoki S, Kunimatsu A, Yamasue H, et al. Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel based analysis. NMR Biomed. 2004; 17:411-6.
49. Agosta F, Pagani E, Rocca M A, Caputo D, Perini M, Salvi F, et al. Voxel based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp. 2007; 28:1430-8.
50. RR, Gorner A, Robberecht W, Sunaert S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage. 2007; 34:486-99.
51. Muller H P, Lule D, Unrath A, Ludolph AC, Riecker A, Kassubek J. Complementary image analysis of diffusion tensor imaging and three-dimensional t1-weighted imaging: white matter analysis in amyotrophic lateral sclerosis. J Neuroimaging. 2011; 21:24-33.
52. Keil C, Prell T, Peschel T, Hartung V, Dengler R, Grosskreutz J. Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci. 2012; 13:141.
53. Chang JL, Lomen-Hoerth C, Murphy J, Henry RG, Kramer JH, Miller BL, et al. A voxel based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology. 2005; 65:75-80.
54. Grosskreutz J, Kaufmann J, Fraedrich J, Dengler R, Heinze HJ, Peschel T. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol. 2006; 6:17.
55. Mezzapesa DM, Ceccarelli A, Dicuonzo F, Carella A, de Caro MF, Lopez M, et al. Whole brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2007; 28:255-9.
56. Senda J, Kato S, Kaga T, Ito M, Atsuta N, Nakamura T, et al. Progressive and widespread brain damage in ALS: MRI voxel based morphometry and diffusion tensor imaging study. Amyotroph Lateral Scler. 2011; 12:59-69.
57. Canu E, Agosta F, Riva N, Sala S, Prelle A, Caputo D, et al. The topography of brain microstructural damage in amyotrophic lateral sclerosis assessed using diffusion tensor MR imaging. AJNR Am J Neuroradiol. 2011; 32:1307-14.
58. Polvikoski TM, Murray A, Harper P S, Neal J W. F amilial motor neuron disease with dementia: phenotypic variation and cerebellar pathology. J Neurol Neurosurg Psychiatry. 2003; 74:1516-20.
59. Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008; 65:636-41.
60. Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9orf72. Acta Neuropathol. 2011; 122:673-90.
61. Abrahams S, Goldstein L H, Suckling J, Ng V, Simmons A, Chitnis X, et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol. 2005; 252:321-31.
62. E llis C M, Suckling J, Amaro E Jr, Bullmore E T, Simmons A, Williams SC, et al. Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology. 2001; 57:1571-8.
63. Minnerop M, Specht K, Ruhlmann J, Grothe C, Wullner U, Klockgether T. In vivo voxel based relaxometry in amyotrophic lateral sclerosis. J Neurol. 2009; 256:28-34.